This Article Full Text Full Text (PDF) All Versions of this Article: 148/10/4676    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Martin, M. B. Articles by Stoica, A. Search for Related Content PubMed PubMed Citation Articles by Martin, M. B. Articles by Stoica, A.

Effects of Tobacco Smoke Condensate on Estrogen Receptor- Gene Expression and Activity

Departments of Oncology (M.B.M., R.R., M.J., B.S., A.S.) and Biostatistics, Bioinformatics, and Biomathematics (A.W.), School of Nursing and Health Studies (M.S.S., M.C.I., J.K.R., A.S.), Georgetown University, Washington, D.C. 20007

Address all correspondence and requests for reprints to: Adriana Stoica, Department of Human Science, School of Nursing and Health Studies, and Department of Oncology, Lombardi Comprehensive Cancer Center, 260 STM, Georgetown University, 3700 Reservoir Road Northwest, Washington, D.C. 20057-1107. E-mail: stoicaa{at}georgetown.edu.

Metallo-estrogens are a new class of potent environmental estrogens. This study investigates whether tobacco smoke condensate (TSC), which contains metals and metalloids, elicits estrogen-like effects at environmentally relevant doses. Treatment of human breast cancer cells, MCF-7, with 40 µg/ml TSC resulted in a 2.5-fold stimulation of cell growth. TSC decreased the concentration of estrogen receptor (ER)- protein and mRNA (63 and 62%, respectively), and increased the expression of the estrogen-regulated genes, progesterone receptor and pS2 (5- and 2-fold, respectively). In addition, TSC activated ER- in COS-1 or CHO cells transiently transfected with wild-type ER- and an ERE-CAT or an ERE-luciferase reporter gene (11- and 6-fold, respectively). TSC also activated a chimeric receptor (GAL-ER) containing the hormone binding domain of ER- (3.5-fold). It blocked the binding of estradiol to the receptor without altering the affinity of estradiol (K_d = 2.2–6.8 x 10^–10 M). Transfection assays with ER- mutants identified C381, C447, H524, N532, E523, and D538 in the hormone binding domain as important for activation by TSC. In ovariectomized rats, low doses of TSC [10 or 20 mg/kg body weight (bw)] increased uterine wet weight (1.7- and 2.1-fold), and induced the expression of progesterone receptor and complement C3 in the uterus (2- and 26-fold) and mammary gland (4.4- and 15-fold). Both the in vitro and in vivo TSC effects were blocked by the antiestrogen ICI 182,780, suggesting the involvement of ER. Collectively, these results provide strong evidence that low doses of TSC, acting through the hormone binding domain, exert estrogen-like effects in cell culture and animals.